105 related articles for article (PubMed ID: 8630659)
1. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris.
Thompson SG; Fechtrup C; Squire E; Heyse U; Breithardt G; van de Loo JC; Kienast J
Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):357-62. PubMed ID: 8630659
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm.
Held C; Hjemdahl P; Håkan Wallén N; Björkander I; Forslund L; Wiman B; Rehnqvist N
Atherosclerosis; 2000 Jan; 148(1):179-88. PubMed ID: 10580184
[TBL] [Abstract][Full Text] [Related]
4. Low normal level of protein C or of antithrombin increases risk for recurrent cardiovascular events.
Pelkonen KM; Wartiovaara-Kautto U; Nieminen MS; Ahonen K; Sinisalo J
Blood Coagul Fibrinolysis; 2005 Jun; 16(4):275-80. PubMed ID: 15870547
[TBL] [Abstract][Full Text] [Related]
5. Functional and antigenic antithrombin III in angina pectoris and acute myocardial infarction patients.
Vonica A; Văgăonescu T; Cristea A; Stăncioiu N
Med Interne; 1990; 28(4):311-7. PubMed ID: 2100876
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.
Fisman EZ; Benderly M; Esper RJ; Behar S; Boyko V; Adler Y; Tanne D; Matas Z; Tenenbaum A
Am J Cardiol; 2006 Jul; 98(1):14-8. PubMed ID: 16784912
[TBL] [Abstract][Full Text] [Related]
7. Short-term prognostic value of lipid measurements in patients with angina pectoris. The ECAT Angina Pectoris Study Group: European Concerted Action on Thrombosis and Disabilities.
Bolibar I; von Eckardstein A; Assmann G; Thompson S;
Thromb Haemost; 2000 Dec; 84(6):955-60. PubMed ID: 11154140
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of hemostatic factors for sudden death in patients with stable angina pectoris.
Benchimol D; Dartigues JF; Benchimol H; Drouillet F; Lauribe P; Marazanof M; Couffinhal T; Bonnet J
Am J Cardiol; 1995 Aug; 76(4):241-4. PubMed ID: 7618616
[TBL] [Abstract][Full Text] [Related]
9. Short- and long-term risk factors for sudden death in patients with stable angina.
Benchimol D; Dubroca B; Bernard V; Lavie J; Paviot B; Benchimol H; Couffinhal T; Pillois X; Dartigues J; Bonnet J
Int J Cardiol; 2000; 76(2-3):147-56. PubMed ID: 11104869
[TBL] [Abstract][Full Text] [Related]
10. The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris Group.
Haverkate F; Thompson SG; van de Loo JC
Ann Epidemiol; 1992 Jul; 2(4):521-4. PubMed ID: 1342302
[TBL] [Abstract][Full Text] [Related]
11. Atherogenic, hemostatic, and other potential risk markers in subjects with previous isolated myocardial infarction compared with long-standing uncomplicated stable angina.
Bogaty P; Robitaille NM; Solymoss S; Boyer L; Auger D; Labbé L; Simard S; Rail J; Genest J; Turgeon J
Am Heart J; 1998 Nov; 136(5):884-93. PubMed ID: 9812085
[TBL] [Abstract][Full Text] [Related]
12. [Lipoprotein(a) and hemostasis activation markers in angina pectoris].
Tsakiris DA; Riesen WF; Marbet GA
Dtsch Med Wochenschr; 1995 Aug; 120(33):1109-13. PubMed ID: 7656834
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
Gold HK; Torres FW; Garabedian HD; Werner W; Jang IK; Khan A; Hagstrom JN; Yasuda T; Leinbach RC; Newell JB
J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.
Zebrack JS; Anderson JL; Maycock CA; Horne BD; Bair TL; Muhlestein JB;
Am J Cardiol; 2002 Jan; 89(2):145-9. PubMed ID: 11792332
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of elevated hemostatic markers in patients with acute myocardial infarction.
Li YH; Teng JK; Tsai WC; Tsai LM; Lin LJ; Guo HR; Chen JH
J Am Coll Cardiol; 1999 May; 33(6):1543-8. PubMed ID: 10334421
[TBL] [Abstract][Full Text] [Related]
16. The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.
Cortellaro M; Boschetti C; Cofrancesco E; Zanussi C; Catalano M; de Gaetano G; Gabrielli L; Lombardi B; Specchia G; Tavazzi L
Arterioscler Thromb; 1992 Sep; 12(9):1063-70. PubMed ID: 1525121
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
Cavusoglu Y; Gorenek B; Alpsoy S; Unalir A; Ata N; Timuralp B
Isr Med Assoc J; 2001 Jan; 3(1):13-6. PubMed ID: 11344793
[TBL] [Abstract][Full Text] [Related]
18. Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III.
Ford ES; Giles WH
J Clin Epidemiol; 2000 Jan; 53(1):95-102. PubMed ID: 10693909
[TBL] [Abstract][Full Text] [Related]
19. Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group.
Haverkate F; Thompson SG; Duckert F
Thromb Haemost; 1995 Apr; 73(4):561-7. PubMed ID: 7495059
[TBL] [Abstract][Full Text] [Related]
20. Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris.
Strand E; Pedersen ER; Svingen GF; Olsen T; Bjørndal B; Karlsson T; Dierkes J; Njølstad PR; Mellgren G; Tell GS; Berge RK; Svardal A; Nygård O
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
